TCL Archive DCBDC Advisors Set aside $2 Mil. For Research On The Microenvironment of Breast Cancer July 9, 1993
TCL Archive In Brief: In Vitro Systems Will Be 90% Reliable, Ames Says; GAO Asks For Reassessment of Saccharin October 1, 1976
TCL Archive Study: Drug Discounts Used For Wealthier Patients In Many 340B-Enrolled Hospitals October 10, 2014
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
